株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染症体外診断 (IVD)の世界市場:製品別、技術別、アプリケーション別、最終用途別、地域別市場分析、シェア、動向、規模、予測(2020~2026年)

Infectious Diseases In Vitro Diagnostics Market, By Product, By Technology, By Application, By End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

発行 AnalystView Market Insights 商品コード 941401
出版日 ページ情報 英文 190 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
感染症体外診断 (IVD)の世界市場:製品別、技術別、アプリケーション別、最終用途別、地域別市場分析、シェア、動向、規模、予測(2020~2026年) Infectious Diseases In Vitro Diagnostics Market, By Product, By Technology, By Application, By End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日: 2020年06月01日 ページ情報: 英文 190 Pages
概要

世界の感染症体外診断 (IVD)市場は、2019年までに161億米ドルと評価され、予測期間中の2020年から2026年の間に7.3%のCAGRで成長する見込みです。

有利な政府のイニシアチブと研究開発目的の外部資金の増加は、世界の感染症体外診断市場の成長を促進する主要な要因となっています。さらに、世界中で増加している老齢人口もまた、市場成長を後押ししています。国連の世界人口高齢化レポート(UN)によると、2019年の80歳以上の高齢者の数は1億4,300万人と推定され、2050年末までに4億2,600万人に達すると予測されています。セルフケア臨床機器へのシフト、健康への意識の高まり、標的疾患の負担の増加は、感染症IVD市場の成長に貢献しています。逆に、厳格な規制の枠組みと体外診断検査に関する費用の不足が予測期間中の市場の成長を阻害すると予測されています。また、患者のコンプライアンス、感度、速度が向上したIVDキットの進歩により、今後の世界の市場で有益な機会が生まれる可能性があります。

当レポートでは、世界の感染症体外診断 (IVD)市場について調査分析し、市場概要、市場動向、産業分析、市場情勢、セグメント別の市場分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 体外診断薬市場での感染症の市場概要

  • 調査範囲
  • 仮定と調査手法

第2章 エグゼクティブサマリー

  • 市場区分
    • 製品別市場
    • 技術別市場
    • アプリケーション別市場
    • 最終用途別市場
    • 地域別市場
  • 競合考察

第3章 主要な市場動向

  • 市場成長要因
    • 市場成長要因の影響分析
  • 市場阻害要因
    • 市場阻害要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 業界研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制フレームワーク分析
  • COVID-19影響分析
    • COVID-19以前の影響分析
    • COVID-19以降の影響分析

第5章 市場情勢

  • 市場シェア分析
  • 主な革新者
  • 主要メーカー別の内訳データ
    • 既存企業分析
    • 新興企業分析

第6章 製品別市場

  • 概要
    • セグメントシェア分析、製品別、2019および2026(%)
  • 試薬
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 器具
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • ソフトウェア
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • その他
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)

第7章 技術別市場

  • 概要
    • セグメント別シェア分析、技術別、2019&2026(%)
  • 分子診断
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 免疫化学
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 微生物学
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • その他
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)

第8章 アプリケーション別市場

  • 概要
    • セグメントシェア分析、アプリケーション別、2019&2026(%)
  • 淋病
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • HPV
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • HIV
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • MRSA
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 連鎖球菌
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • クロストリジウムディフィシル
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • VRE
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 結核と薬剤耐性結核
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 胃腸パネル検査
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • B型肝炎
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • C型肝炎
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • CRE
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 呼吸器ウイルス
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • カンジダ
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • クラミジア
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • その他
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)

第9章 最終用途別市場

  • 概要
    • セグメントシェア分析、最終用途別、2019&2026(%)
  • 中央検査室
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • ポイントオブケア(POC)
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • その他
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)

第10章 地域別市場

  • イントロダクション
    • 地域別セグメントシェア分析、2019年および2026年(%)
  • 北米
    • 概要
    • 北米の主要メーカー
    • 北米の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 北米の市場規模と予測、製品別、2015年-2026年(百万米ドル)
    • 北米の市場規模と予測、アプリケーション別、2015年-2026年(百万米ドル)
    • 北米の市場規模と予測、最終用途別、2015年-2026年(百万米ドル)
    • 北米の市場規模と予測、技術別、2015年-2026年(百万米ドル)
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • 欧州の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 欧州の市場規模および予測、製品別、2015年-2026(百万米ドル)
    • 欧州の市場規模と予測、アプリケーション別、2015年-2026年(百万米ドル)
    • 欧州の市場規模と予測、最終用途別、2015~2026年(百万米ドル)
    • 欧州の市場規模および予測、技術別、2015年-2026年(百万米ドル)
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • アジア太平洋の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • アジア太平洋の市場規模と予測、製品別、2015年-2026年(百万米ドル)
    • アジア太平洋市場の規模と予測、アプリケーション別、2015年-2026年(百万米ドル)
    • アジア太平洋の市場規模と予測、最終用途別、2015年-2026年(百万米ドル)
    • アジア太平洋の市場規模と予測、技術別、2015年-2026年(百万米ドル)
    • インド
    • 中国
    • 日本
    • 韓国
    • その他のアジア太平洋諸国
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ラテンアメリカの市場規模と予測、国別、2015年-2026年(百万米ドル)
    • ラテンアメリカの市場規模と予測、製品別、2015年-2026年(百万米ドル)
    • ラテンアメリカの市場規模と予測、アプリケーション別、2015年-2026年(百万米ドル)
    • ラテンアメリカの市場規模と予測、最終用途別、2015年-2026年(百万米ドル)
    • ラテンアメリカの市場規模と予測、技術別、2015年-2026年(百万米ドル)
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ諸国
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • 中東・アフリカの市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 中東・アフリカの市場規模と予測、アプリケーション別、2015年-2026年(百万米ドル)
    • 中東・アフリカの市場規模と予測、最終用途別、2015年-2026年(百万米ドル)
    • 中東・アフリカの市場規模と予測、製品別、2015~2026年(百万米ドル)
    • 中東・アフリカの市場規模と予測、技術別、2015年-2026年(百万米ドル)
    • サウジアラビア
    • アラブ首長国連邦

第11章 ベンダーの分析

  • Abbott
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • bioMerieux SA
  • Cepheid
  • Qiagen NV
  • Hologic Inc.
  • Siemens ヘルスケア GmbH
  • Alere Inc.
  • Quidel Corporation
  • Orasure Technologies
  • F. Hoffmann-La Roche Ltd.

第12章 アナリストの多角的分析

第13章 付録

  • 調査方法
  • 参考文献
  • 略語
  • 免責事項
  • お問い合わせ
図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infectious Diseases In Vitro Diagnostics market: Product Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Product 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Technology Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Technology 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Application 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by End Use 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Region 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Country, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infectious Diseases In Vitro Diagnostics market: Product Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Product 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Technology Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Technology 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Application 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by End Use 2015-2026 (USD Million)
  • TABLE Infectious Diseases In Vitro Diagnostics market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infectious Diseases In Vitro Diagnostics market, by Region 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Country, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE North America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

List of Figures

  • FIGURE Infectious Diseases In Vitro Diagnostics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Product segment market share analysis, 2019 & 2026
  • FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Molecular Diagnostics segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Immunochemistry segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Microbiology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Technology segment market share analysis, 2019 & 2026
  • FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End Use segment market share analysis, 2019 & 2026
  • FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Infectious Diseases In Vitro Diagnostics market share and leading players, 2018
  • FIGURE Europe Infectious Diseases In Vitro Diagnostics market share and leading players, 2018
  • FIGURE Asia Pacific Infectious Diseases In Vitro Diagnostics market share and leading players, 2018
  • FIGURE Latin America Infectious Diseases In Vitro Diagnostics market share and leading players, 2018
  • FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market share and leading players, 2018
  • FIGURE North America Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018
  • FIGURE U.S. Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018
  • FIGURE Germany Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018
  • FIGURE India Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018
  • FIGURE Brazil Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018
  • FIGURE Saudi Arabia Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Infectious Diseases In Vitro Diagnostics market was valued at USD 16.1 billion by 2019, growing with 7.3% CAGR during the forecast period, 2020-2026

Market Dynamics

The favorable government initiatives and the rise in external funds for R&D purposes are some of the major factors driving the growth of global infectious diseases in vitro diagnostics market. In addition, the increasing geriatric population all across the globe are other key factors boosting the market growth. According to the World Population Aging Report by United Nations (UN), in 2019, the number of elderly people aged 80 years and older were estimated for 143 million and this number is projected to reach 426 million by the end of 2050. Moreover, the shift towards self-care clinical devices, growing health awareness, and the rising burden of target diseases are some of the contributors to the growth of the global market for infectious diseases IVD market. Conversely, a dearth of stringent regulatory framework and expenses associated with in-vitro diagnostic tests are predicted to hinder the market growth during the forecast period. Furthermore, the advancements in IVD kits such as improved patient compliance, sensitivity, and speed is likely to create lucrative opportunities in the global market in the coming future.

Presently, the North America region is playing a leading role in the global infectious diseases IVD market and is estimated to dominate the industry throughout the forecast. This dominance is attributed to the presence of well-established healthcare infrastructure, proactive government initiatives, and growing awareness levels of patients and practitioners in this region.

Further key findings of the report suggest:

  • The reagents product segment held the largest market share in the overall market in 2019 and is expected to grow at a healthy rate during the forecast period. This is mainly due to increasing demand for point-of-care & self-test products and the growth in the number of R&D initiatives related to molecular diagnostic tools.
  • The HIV tests segment valued for the majority of share in the infectious diseases IVD market in 2019 owing to the rapidly rising disease burden and highly unmet medical needs in the developing countries.
  • The immunochemistry technology segment accounted for the highest revenue share in the worldwide industry in 2019, followed thoroughly by molecular diagnostics. Nevertheless, molecular diagnostics technology is projected to be the largest segment by the end of 2030. This is mainly due to the increasing demand for rapid new-age, accurate, and sensitive devices and rising penetration for diagnosing infectious diseases.
  • The central laboratories end use segment emerged as the largest in 2019, which is primarily driven by the large volume of tests carried out these laboratories. On the other hand, the point-of-care (PoC) end use segment is projected to witness the highest growth rate during the period of forecast. This is majorly owing to the rising need for rapid diagnosing and the increase in initiatives intended to lessen hospital stays to bound healthcare expenditure.
  • The Asia Pacific market for infectious diseases IVD is projected to record the highest growth rate in the estimated period owing to the high unmet medical needs, presence of favorable government initiatives for testing infectious disease, the rise in healthcare spending in countries such as India, China, South Korea, and an increase in disposable income in this region.
  • Key participants of the overall infectious diseases IVD market include bioMerieux SA, Alere Inc., Abbott, Quidel Corporation, Orasure Technologies, Inc., F. Hoffmann-La Roche Ltd., Cepheid, Qiagen N.V., Hologic Inc., and Siemens Healthcare GmbH.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2015 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY

  • Molecular Diagnostics
  • Immunochemistry
  • Microbiology
  • Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY PRODUCT

  • Reagents
  • Instruments
  • Software
  • Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

  • Gonorrhoea
  • HPV
  • HIV
  • MRSA
  • Streptococcus
  • Clostridium Difficile
  • VRE
  • TB and Drug-resistant TB
  • Gastro-intestinal Panel Testing
  • Hepatitis B
  • Hepatitis C
  • CRE
  • Respiratory Virus
  • Candida
  • Chlamydia
  • Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY END USE

  • Central Laboratories
  • Point of Care
  • Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Product
    • 2.1.2. Market Snippet by Technology
    • 2.1.3. Market Snippet by Application
    • 2.1.4. Market Snippet by End Use
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET - BY PRODUCT

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
  • 6.2. Reagents
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Instruments
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Software
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Others
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET - BY TECHNOLOGY

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
  • 7.2. Molecular Diagnostics
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Immunochemistry
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Microbiology
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Others
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET - BY APPLICATION

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 8.2. Gonorrhoea
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. HPV
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. HIV
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. MRSA
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.6. Streptococcus
    • 8.6.1. Overview
    • 8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.7. Clostridium Difficile
    • 8.7.1. Overview
    • 8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.8. VRE
    • 8.8.1. Overview
    • 8.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.9. TB and Drug-resistant TB
    • 8.9.1. Overview
    • 8.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.10. Gastro-intestinal Panel Testing
    • 8.10.1. Overview
    • 8.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.11. Hepatitis B
    • 8.11.1. Overview
    • 8.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.12. Hepatitis C
    • 8.12.1. Overview
    • 8.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.13. CRE
    • 8.13.1. Overview
    • 8.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.14. Respiratory Virus
    • 8.14.1. Overview
    • 8.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.15. Candida
    • 8.15.1. Overview
    • 8.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.16. Chlamydia
    • 8.16.1. Overview
    • 8.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.17. Others
    • 8.17.1. Overview
    • 8.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET - BY END USE

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 9.2. Central Laboratories
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Point of Care
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Others
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. Abbott
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. bioMerieux SA
  • 11.3. Cepheid
  • 11.4. Qiagen N.V.
  • 11.5. Hologic Inc.
  • 11.6. Siemens Healthcare GmbH
  • 11.7. Alere Inc.
  • 11.8. Quidel Corporation
  • 11.9. Orasure Technologies
  • 11.10. F. Hoffmann-La Roche Ltd.

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us